SCHEMBL21095211

SCHEMBL21095211

C=C(CO)Oc1cc2c(cc1OC)CCN(C)[C@H]2Cc1ccc(Oc2cc(CC)ccc2OC)cc1

nearest known ligand 0.73

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.64
LMNA P02545 2/20 0.61
KDM4E B2RXH2 2/20 0.61
ALDH1A1 P00352 2/20 0.61
HSD17B10 Q99714 2/20 0.61
MAPK1 P28482 1/20 0.61
CYP2D6 P10635 1/20 0.61
ALOX15 P16050 1/20 0.58
BCHE P06276 1/20 0.54
ACHE P22303 1/20 0.54
DRD2 P14416 1/20 0.54
DRD1 P21728 1/20 0.54
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21095124 0.90 LMNA (0.75) KCNH2LMNAKDM4EALDH1A1HSD17B10
Dimethylgrisabine SCHEMBL30735570 0.85 LMNA (0.84) KCNH2LMNAKDM4EALDH1A1HSD17B10
SCHEMBL29819356 0.81 KCNH2 (0.81) KCNH2LMNAKDM4EALDH1A1HSD17B10
SCHEMBL32690224 0.80 KCNH2 (0.85) KCNH2LMNAKDM4EALDH1A1HSD17B10
SCHEMBL21346112 0.79 LMNA (0.93) KCNH2LMNAKDM4EALDH1A1HSD17B10
Dauricine SCHEMBL22089144 0.79 KCNH2 (1.00) KCNH2LMNAKDM4EALDH1A1HSD17B10
Dauricine SCHEMBL2233953 0.79 KCNH2 (1.00) KCNH2LMNAKDM4EALDH1A1HSD17B10
Dauricine SCHEMBL29494084 0.79 KCNH2 (1.00) KCNH2LMNAKDM4EALDH1A1HSD17B10
Dauricine SCHEMBL28689430 0.79 KCNH2 (1.00) KCNH2LMNAKDM4EALDH1A1HSD17B10
Dauricine SCHEMBL29494083 0.79 KCNH2 (1.00) KCNH2LMNAKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805954-B1 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF HANGZHOU BENSHENG PHARMACEUTICAL CO LTD (CN) 2019-06-19 EP disclosed